Michael Vogelbaum MD, PhD
Cited by
Cited by
Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group
PY Wen, DR Macdonald, DA Reardon, TF Cloughesy, AG Sorensen, ...
Journal of clinical oncology 28 (11), 1963-1972, 2010
A randomized trial of bevacizumab for newly diagnosed glioblastoma
MR Gilbert, JJ Dignam, TS Armstrong, JS Wefel, DT Blumenthal, ...
New England Journal of Medicine 370 (8), 699-708, 2014
Radiotherapeutic and surgical management for newly diagnosed brain metastasis (es): An American Society for Radiation Oncology evidence-based guideline
MN Tsao, D Rades, A Wirth, SS Lo, BL Danielson, LE Gaspar, ...
Practical radiation oncology 2 (3), 210-225, 2012
Inhibition of constitutively active Stat3 suppresses proliferation and induces apoptosis in glioblastoma multiforme cells
SO Rahaman, PC Harbor, O Chernova, GH Barnett, MA Vogelbaum, ...
Oncogene 21 (55), 8404-8413, 2002
Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas
MJ van den Bent, JS Wefel, D Schiff, MJB Taphoorn, K Jaeckle, L Junck, ...
The lancet oncology 12 (6), 583-593, 2011
Response assessment criteria for brain metastases: proposal from the RANO group
NU Lin, EQ Lee, H Aoyama, IJ Barani, DP Barboriak, BG Baumert, ...
The lancet oncology 16 (6), e270-e278, 2015
Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma
S Kunwar, S Chang, M Westphal, M Vogelbaum, J Sampson, G Barnett, ...
Neuro-oncology 12 (8), 871-881, 2010
Serum S100β: A noninvasive marker of blood‐brain barrier function and brain lesions
AA Kanner, N Marchi, V Fazio, MR Mayberg, MT Koltz, V Siomin, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 2003
Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas
NL Albert, M Weller, B Suchorska, N Galldiks, R Soffietti, MM Kim, ...
Neuro-oncology 18 (9), 1199-1208, 2016
Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review
L Rogers, I Barani, M Chamberlain, TJ Kaley, M McDermott, J Raizer, ...
Journal of neurosurgery 122 (1), 4-23, 2015
Consensus recommendations for a standardized brain tumor imaging protocol in clinical trials
BM Ellingson, M Bendszus, J Boxerman, D Barboriak, BJ Erickson, ...
Neuro-oncology 17 (9), 1188-1198, 2015
Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma
B Raychaudhuri, P Rayman, J Ireland, J Ko, B Rini, EC Borden, J Garcia, ...
Neuro-oncology 13 (6), 591-599, 2011
End point assessment in gliomas: novel treatments limit usefulness of classical Macdonald's Criteria
MJ van den Bent, MA Vogelbaum, PY Wen, DR Macdonald, SM Chang
Journal of Clinical Oncology 27 (18), 2905, 2009
Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma
MM Grabowski, PF Recinos, AS Nowacki, JL Schroeder, L Angelov, ...
Journal of neurosurgery 121 (5), 1115-1123, 2014
Poor drug distribution as a possible explanation for the results of the PRECISE trial
JH Sampson, G Archer, C Pedain, E Wembacher-Schröder, M Westphal, ...
Journal of neurosurgery 113 (2), 301-309, 2010
Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme
DM Peereboom, DR Shepard, MS Ahluwalia, CJ Brewer, N Agarwal, ...
Journal of neuro-oncology 98 (1), 93-99, 2010
Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3 …
MJ van den Bent, B Baumert, SC Erridge, MA Vogelbaum, AK Nowak, ...
The Lancet 390 (10103), 1645-1653, 2017
Application of novel response/progression measures for surgically delivered therapies for gliomas: Response Assessment in Neuro-Oncology (RANO) Working Group
MA Vogelbaum, S Jost, MK Aghi, AB Heimberger, JH Sampson, PY Wen, ...
Neurosurgery 70 (1), 234-244, 2012
In touch with robotics: neurosurgery for the future
N Nathoo, MC Çavuşoğlu, MA Vogelbaum, GH Barnett
Neurosurgery 56 (3), 421-433, 2005
Phase II trial of pazopanib (GW786034), an oral multi-targeted angiogenesis inhibitor, for adults with recurrent glioblastoma (North American Brain Tumor Consortium Study 06-02)
FM Iwamoto, KR Lamborn, HI Robins, MP Mehta, SM Chang, ...
Neuro-oncology 12 (8), 855-861, 2010
The system can't perform the operation now. Try again later.
Articles 1–20